Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2023-04-06 Regulatory Filings
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Zawarcie aneksu z Novavax, Inc. w zakresie wytwarzania antygenu szczepionki na COVID-19: wariant Omicron - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is written in Polish and discusses an amendment (Aneks nr 2) to a Master Contract Manufacturing Agreement (Umowa) between Mabion S.A. and Novavax, Inc. The amendment concerns the production of an Omicron variant COVID-19 vaccine antigen. This type of communication, detailing a specific contractual change, amendment to a manufacturing agreement, or a significant operational update that is not a standard financial report (like 10-K or IR) or a general regulatory filing (RNS), fits best under Capital/Financing Update (CAP) if it relates to capacity/production contracts, or potentially Regulatory Filings (RNS) if it's a mandatory disclosure in the local market. Given the context of a specific contractual amendment impacting production capabilities and collaboration, and lacking keywords for earnings, dividends, or management changes, it is a specific corporate action disclosure. Since there is no direct category for 'Contract Amendment' and it is a material operational update, it is most appropriately classified as a general Regulatory Filing (RNS) as a specific disclosure that doesn't fit the other detailed categories, or potentially CAP if the contract change implies a significant financing/capacity shift. Given the nature of amending a manufacturing agreement, RNS is the safest fallback for specific, non-financial, material corporate news not covered elsewhere. However, since it details a change in operational scope and capacity utilization related to a major contract, it is a significant corporate event disclosure. I will classify it as RNS as the most appropriate general regulatory disclosure category for material operational news not covered by other specific codes.
2023-04-06 Polish
Rozszerzenie zakresu współpracy z Novavax, Inc. - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement in Polish (Raport bieżący) detailing a specific contractual expansion (SOW#10) between Mabion S.A. and Novavax regarding logistical services (transport and storage) related to vaccine production. This concerns a change or update to an existing commercial agreement, specifically detailing new services and their estimated value (1.2 million PLN in the first year). This type of announcement, which details specific business transactions, contract amendments, or financing/commercial updates that are not standard periodic financial reports (10-K, IR) or management discussions (MDA), fits best under a general regulatory announcement or a specific business transaction category. Since it details a commercial agreement expansion and its financial impact, it is a significant business update. Given the options, it is a specific regulatory filing/announcement. It is not an Earnings Release (ER), Interim Report (IR), or a standard M&A activity (TAR). It is a specific business update that doesn't perfectly match the highly specific categories like DIV, DIRS, or NAV. Therefore, the most appropriate fallback category for a significant, non-standard regulatory business update is 'Regulatory Filings' (RNS). The document length is short (1338 chars), but it contains the full substance of the announcement, not just a notice to download another report, thus RPA is less likely than RNS for substantive business news.
2023-02-09 Polish
Rozwiązanie niewiążącego porozumienia z Polskim Funduszem Rozwoju S.A. - Content (PL)
Capital/Financing Update Classification · 99% confidence The document text is very short (879 characters) and discusses the resolution of a non-binding agreement concerning an investment from the Polish Development Fund (PFR) following the securing of a loan from the European Bank for Reconstruction and Development (EBRD). This relates to capital structure changes, financing activities, and the termination of a prior investment commitment. This strongly aligns with the 'Capital/Financing Update' category (CAP). It is not a full report, an earnings release, or a management discussion, but a specific corporate action announcement regarding financing.
2023-02-06 Polish
Podpisanie umowy kredytu na kwotę 15.000.000 USD z Europejskim Bankiem Odbudowy i Rozwoju - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text describes the execution of a loan agreement (Umowa Kredytu) for $15,000,000 USD between Mabion S.A. and the European Bank for Reconstruction and Development (EBOR). The loan is intended to finance the expansion and modernization of the company's facility to support contract manufacturing, referencing specific repayment schedules, interest rates (SOFR + margin), collateral (mortgage, pledges), and financial covenants (including DSCR and CAPEX limits). This clearly relates to the company's financing activities and capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document is a detailed report of the agreement, not just an announcement of a report (RPA/RNS).
2023-02-06 Polish
Terminy przekazywania raportów okresowych w roku obrotowym 2023 - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text is very short (579 characters) and explicitly states the dates on which the company (Mabion S.A.) will release its periodic reports (annual, quarterly, semi-annual) for the year 2023. It cites a specific Polish regulation (Rozporządzenia Ministra Finansów) as the basis for the announcement. Because this document is an announcement *about* the timing of future reports, rather than the reports themselves, it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that RPA specifically covers announcements regarding the timing/release of reports, RPA is the most precise fit, although RNS is a possible fallback.
2023-01-25 Polish
Oświadczenie KDPW w sprawie asymilacji akcji zwykłych na okaziciela serii S Spółki - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short announcement (762 characters) from the Management Board of Mabion S.A. It explicitly states that the company received information regarding the assimilation of 500 bearer shares into the main trading system of the Warsaw Stock Exchange, effective December 16, 2022. This action relates to the introduction of previously unlisted shares into public trading. This is a specific corporate action concerning capital structure/share status, which aligns best with 'Share Issue/Capital Change' (SHA) or potentially a general regulatory filing (RNS). Since it details the final step of introducing shares to the market, SHA is the most precise fit, although it is an announcement about a capital event rather than the primary filing itself. Given the context of share introduction/assimilation, SHA is appropriate. It is not a general regulatory filing (RNS) because a more specific category exists.
2022-12-13 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.